| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 69.103 | 79.827 | 78.756 | 76.219 | 86.963 | 96.649 | 100.846 | 113.785 | 133.827 |
| Total Income - EUR | - | 69.103 | 79.827 | 78.761 | 76.219 | 86.963 | 96.649 | 102.910 | 113.785 | 133.834 |
| Total Expenses - EUR | - | 9.952 | 8.847 | 11.334 | 19.297 | 19.548 | 18.258 | 21.495 | 17.416 | 26.106 |
| Gross Profit/Loss - EUR | - | 59.150 | 70.979 | 67.426 | 56.922 | 67.415 | 78.390 | 81.414 | 96.369 | 107.728 |
| Net Profit/Loss - EUR | - | 57.077 | 68.585 | 65.063 | 54.636 | 64.923 | 75.549 | 79.026 | 95.402 | 103.793 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Til Obginmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 1.731 | 5.383 | 6.791 | 35.876 | 23.347 | 12.915 | 2.700 | 360 | 22.537 |
| Current Assets | - | 55.984 | 63.881 | 59.143 | 65.564 | 58.606 | 64.032 | 76.834 | 119.940 | 83.280 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 3.172 | 85 | 0 | 125 | 56.993 | 6.246 | 3.291 |
| Cash | - | 55.984 | 63.881 | 55.971 | 65.479 | 58.606 | 63.907 | 19.841 | 113.694 | 79.989 |
| Shareholders Funds | - | 57.122 | 68.629 | 65.115 | 100.744 | 81.064 | 76.084 | 79.075 | 120.336 | 103.841 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 682 | 636 | 819 | 696 | 902 | 901 | 504 | 92 | 2.147 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Til Obginmed Srl